跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Health Canada
/
SANDOZ ESOMEPRAZOLE
Authorized
STANDARD
SANDOZ ESOMEPRAZOLE
Sandoz Canada, Inc.
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
d9dcdcf9d843cdc2
Company
Sandoz Canada, Inc.
Type
Standard
Approval Details
Approval Id
d9dcdcf9d843cdc2
Drug Approval Canada Name
SANDOZ ESOMEPRAZOLE
Product Name
SANDOZ ESOMEPRAZOLE
Status
Marketed
Status Date
2018-09-25
Original Market Date
2018-09-25
Din
02460939
Drug Class
Human
Dosage Form
Tablet (Delayed-Release)
Route Of Administration
Oral
Schedule
Prescription
Ahfs
56:28.36
Atc Original
A02BC05 ESOMEPRAZOLE
Atc Name
a 02 bc 05
Aig Number
0145162002
Company Name
Sandoz Canada, Inc.
Company Address
4600 Rue Armand-Frappier, Saint-Hubert, Quebec, Canada, J3Z 1G5
Company Detail Path
/organization/sandoz-canada-inc
Company Information
Pharmaceutical Company Name
Sandoz Canada, Inc.
Country Name
Canada
Website
http://www.sandoz.ca
Active Ingredients
ESOMEPRAZOLE (ESOMEPRAZOLE MAGNESIUM DIHYDRATE)
40 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
d9dcdcf9d843cdc2
Type
Standard
Back to Health Canada Approvals
SANDOZ ESOMEPRAZOLE - Health Canada Drug Approval Details